JP Morgan Chase
ALMR

JP Morgan Chase’s Alamar Biosciences ALMR Stock Holding History

JP Morgan Chase’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
+92,665
New +$2.1M ﹤0.01% 4012

Other funds holding ALMR

SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase's ALMR Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 92,665 shares worth $2.57M. The stake represents ﹤0.01% of the portfolio and ranks #4012 among its holdings.

40 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • JP Morgan Chase held 92,665 shares of Alamar Biosciences worth $2.57M as of Q2 2026.
  • Alamar Biosciences was a new JP Morgan Chase position in Q2 2026.
  • Alamar Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4012 holding.
  • 40 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.